PAR 12.2% 23.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3400

  1. 230 Posts.
    lightbulb Created with Sketch. 12
    i realize this, not saying thats where we should be now but we definitely have the potential to be making 1b+ revenue in the future if we go commercial
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.